Last reviewed · How we verify
Gonadotropin-releasing Hormone
Gonadotropin-releasing Hormone is a Small molecule drug developed by Peking Union Medical College Hospital. It is currently FDA-approved. Also known as: Gonadorelin.
At a glance
| Generic name | Gonadotropin-releasing Hormone |
|---|---|
| Also known as | Gonadorelin |
| Sponsor | Peking Union Medical College Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments (NA)
- Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma (PHASE2)
- CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study) (NA)
- A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer (PHASE2)
- A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma (PHASE2)
- Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients (PHASE2)
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gonadotropin-releasing Hormone CI brief — competitive landscape report
- Gonadotropin-releasing Hormone updates RSS · CI watch RSS
- Peking Union Medical College Hospital portfolio CI
Frequently asked questions about Gonadotropin-releasing Hormone
What is Gonadotropin-releasing Hormone?
Gonadotropin-releasing Hormone is a Small molecule drug developed by Peking Union Medical College Hospital.
Who makes Gonadotropin-releasing Hormone?
Gonadotropin-releasing Hormone is developed and marketed by Peking Union Medical College Hospital (see full Peking Union Medical College Hospital pipeline at /company/peking-union-medical-college-hospital).
Is Gonadotropin-releasing Hormone also known as anything else?
Gonadotropin-releasing Hormone is also known as Gonadorelin.
What development phase is Gonadotropin-releasing Hormone in?
Gonadotropin-releasing Hormone is FDA-approved (marketed).
Related
- Manufacturer: Peking Union Medical College Hospital — full pipeline
- Also known as: Gonadorelin
- Compare: Gonadotropin-releasing Hormone vs similar drugs
- Pricing: Gonadotropin-releasing Hormone cost, discount & access